Doxycycline for Clinical Management of Filarial Lymphedema (India)

Determine whether doxycycline treatment daily for 6 weeks improves clinical outcomes (swelling, acute attacks) in lymphedema patients.

Sites

Implementation partner(s): India MOH
WHO Region: SEARO

Publications

The design and development of a multicentric protocol to investigate the impact of adjunctive doxycycline on the management of peripheral lymphoedema caused by lymphatic filariasis and podoconiosis

Horton, J., Klarmann-Schulz, U., Stephens, M. et al.
2020, Issue no. 13, pages 155

Notes

This project is associated with studies 56.2 and 56.3.

The National Clinical Trials registry number for this project is NCT02929121.

Email primary contact

Please log in or register